Bluefin Capital Management’s BiomX Inc. Warrants to purchase one-half of a share of Common Stock PHGE.WS Stock Holding History

Bluefin Capital Management’s Portfolio PHGE.WS Stock Details PHGE.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-22,400	Closed	-$2K	–	1070
2021 Q4	$2K	Buy	+22,400	New	+$6.07K	﹤0.01%	877
2021 Q3	–	Sell	-22,400	Closed	-$13K	–	945
2021 Q2	$13K	Hold	22,400	–	–	﹤0.01%	586
2021 Q1	$15K	Hold	22,400	–	–	﹤0.01%	685
2020 Q4	$18K	Buy	+22,400	New	+$15.1K	﹤0.01%	601
2020 Q3	–	Sell	-25,000	Closed	-$13.4K	–	425
2020 Q2	$12K	Hold	25,000	–	–	﹤0.01%	348
2020 Q1	$15K	Hold	25,000	–	–	﹤0.01%	372
2019 Q4	$12K	Buy	+25,000	New	+$15.6K	﹤0.01%	530

Other funds holding PHGE.WS

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Bluefin Capital Management's PHGE.WS Position: Q1 2022 in Review

Bluefin Capital Management sold out of BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) in Q1 2022, closing a stake of 22,400 shares — an estimated $2K sold.

Bluefin Capital Management first reported a position in PHGE.WS in Q4 2019 and held it in 7 quarters. The position peaked at $18K in Q4 2020. 11 funds tracked by Wall St. Rank hold PHGE.WS as of Q1 2022.

Bluefin Capital Management reported no remaining BiomX Inc. Warrants to purchase one-half of a share of Common Stock position as of Q1 2022 after selling out during the quarter.
Bluefin Capital Management sold 22,400 BiomX Inc. Warrants to purchase one-half of a share of Common Stock shares in Q1 2022, an estimated $2K.
Bluefin Capital Management first reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in Q4 2019 and held it in 7 quarters.
Bluefin Capital Management's BiomX Inc. Warrants to purchase one-half of a share of Common Stock position peaked at $18K in Q4 2020.
11 funds tracked by Wall St. Rank held BiomX Inc. Warrants to purchase one-half of a share of Common Stock as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.